Role of flow cytometric immunophenotyping in staging of pediatric solid round cell tumors
Not Applicable
- Conditions
- Health Condition 1: null- Newly diagnosed patients with RCT including neuroblastoma rhabdomayosarcoma, EWS/PNET and retinoblastomaAge less or equal to 15 years
- Registration Number
- CTRI/2017/02/007944
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Newly diagnosed patients with RCT including neuroblastoma, rhabdomayosarcoma, EWS/PNET, and retinoblastoma.
Age less or equal to 15 years.
Exclusion Criteria
Patient who is not taking treatment in TMC
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage involvement in bone marrow and peripheral blood by RCTTimepoint: Peripheral blood samples will be collected at the tile of routine bone marrow biopsy
- Secondary Outcome Measures
Name Time Method To evaluate the efficacy of FC immunophenotyping in the detection of metastasis of RCT in the bone marrow.Timepoint: The patients in this study will not have any immediate benefit. With this project, we investigate a sensitive and faster technique for detection and percentage of bone marrow involvement and also circulating tumor cells